High rates of hepatitis B virus (HBV) functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy

被引:2
|
作者
Xia Huan [1 ]
Gao Liying [5 ]
Hu Yue [5 ]
Huang Xiaojie [6 ]
Wu Hao [6 ]
Ma Ping [5 ]
机构
[1] Department of Gastroenterology
[2] Tianjin Second People’s Hospital  3. Tianjin 300192  4. China
[3] Department of Infectious Diseases
[4] Center for Infectious Diseases
[5] Beijing Youan Hospital  8. Capital Medical University  9. Beijing 100069
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R512.91 [获得性免疫缺陷综合征(AIDS艾滋病)]; R512.62 [];
学科分类号
100401 ;
摘要
<正>
引用
收藏
相关论文
共 50 条
  • [31] Acute IRIS-Related HBV Flare Unmasked After Antiretroviral Therapy Initiation in a HIV/HBV Coinfected Patient
    Arshad, Iqra
    Gandhi, Mukti
    Gossai, Marcia
    Feinstein, Addi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2447 - S2448
  • [32] Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
    Gu, Lijun
    Han, Yang
    Li, Yijia
    Zhu, Ting
    Song, Xiaojing
    Huang, Ying
    Yang, Feifei
    Guan, Shuo
    Xie, Jing
    Gohda, Jin
    Hosoya, Noriaki
    Kawana-Tachikawa, Ai
    Liu, Wenjun
    Gao, George Fu
    Iwamoto, Aikichi
    Li, Taisheng
    Ishida, Takaomi
    PLOS ONE, 2015, 10 (08):
  • [33] Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection
    Lascar, RM
    Lopes, AR
    Gilson, RJ
    Dunn, C
    Johnstone, R
    Copas, A
    Reignat, S
    Webster, G
    Bertoletti, A
    Maini, MK
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (07): : 1169 - 1179
  • [34] Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients
    Lacombe, Karine
    Gozlon, Joel
    Boyd, Anders
    Boelle, Pierre-Yves
    Bonnard, Philippe
    Molina, Jean-Michel
    Miailhes, Patrick
    Lascoux-Combe, Caroline
    Serfaty, Lawrence
    Zoulim, Fabien
    Girard, Pierre-Marie
    ANTIVIRAL THERAPY, 2008, 13 (05) : 705 - 713
  • [35] Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study
    Peters, Lars
    Mocroft, Amanda
    Grint, Daniel
    Moreno, Santiago
    Calmy, Alexandra
    Jevtovic, Djordje
    Sambatakou, Helen
    Lacombe, Karine
    De Wit, Stephane
    Rockstroh, Juergen
    Smidt, Jelena
    Karpov, Igor
    Grzeszczuk, Anna
    Haziosmanovic, Vesnadarjan
    Gottfredsson, Magnus
    Radoi, Roxana
    Kuzovatova, Elena
    Orkin, Chloe
    Ridolfo, Anna Lisa
    Zapirain, Jose
    Lundgren, Jens
    ANTIVIRAL THERAPY, 2018, 23 (05) : 405 - 413
  • [36] Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant Recipients
    Coffin, C. S.
    Stock, P. G.
    Dove, L. M.
    Berg, C. L.
    Nissen, N. N.
    Curry, M. P.
    Ragni, M.
    Regenstein, F. G.
    Sherman, K. E.
    Roland, M. E.
    Terrault, N. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1268 - 1275
  • [37] TENOFOVIR-BASED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IS ASSOCIATED WITH HIGH RATES OF HBV DNA SUPPRESSION AND HBEAG SEROCONVERSION IN THAI HIV-HBV COINFECTED PATIENTS
    Matthews, Gail
    Avihingsanon, Anchalee
    Lewin, Sharon
    Sasadeusz, Joe
    Marks, Pip
    Revill, Peter A.
    Ayres, Anna
    Bow-den, Scott
    Locarnini, Stephen
    Thio, Chloe L.
    Ruxrungtham, Kiat
    Dore, Gregory J.
    HEPATOLOGY, 2008, 48 (04) : 712A - 713A
  • [38] Reduced hepatitis B virus (HBV)-specific CD4+ T-Cell responses in human immunodeficiency virus type 1-HBV-Coinfected individuals receiving HBV-active antiretroviral therapy
    Chang, JJ
    Wightman, F
    Bartholorneusz, A
    Ayres, A
    Kent, SJ
    Sasadeusz, J
    Lewin, SR
    JOURNAL OF VIROLOGY, 2005, 79 (05) : 3038 - 3051
  • [39] Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus
    Sulkowski, MS
    Mehta, SH
    Torbenson, M
    Afdhal, NH
    Mirel, L
    Moore, RD
    Thomas, DL
    AIDS, 2005, 19 (06) : 585 - 592
  • [40] Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations
    Audsley, J.
    Arrifin, N.
    Yuen, L. K. W.
    Ayres, A.
    Crowe, S. M.
    Bartholomeusz, A.
    Locarnini, S. A.
    Mijch, A.
    Lewin, S. R.
    Sasadeusz, J.
    HIV MEDICINE, 2009, 10 (04) : 229 - 235